Amino Collective — Pre-Seed & Seed VC Firm

Allcyte

AI for personalized medicine and drug development through image-based quantification of single-cell phenotypes. Acquired by Exscientia and subsequently merged with Recursion.

Anima

Next-generation care, enabled through a combination of online consultation with productivity tools and built with system-wide working at its core for 5x faster patient care.

Calibre

Calibre is empowering consumers to live their healthiest life. It combines diagnostics, clinical expertise, and causal AI to help people understand their health and guide them how to change it.

Cosyne

A new, hypothesis-free approach for drug discovery for the deadliest cancers, using genetic computational systems analysis, powered by polymathic AI.

Cradle

Solving protein design for biologists using powerful prediction algorithms and AI design suggestions to get tailored thermostability, activity, and specificity in record time.

Enveda

Machine learning, metabolomics, and robotics, merged into a drug discovery platform that integrates datasets of anthropological, biological, and chemical information from medicinal plants.

Biomia

Building a drug discovery engine with precision fermentation to find and scale new-to-nature medicines, addressing the unmet medical needs in pain, addiction, and depression.

ExpressionEdits

Redefining the status quo of gene expression for drug development - through the foundational redesign of synthetic DNA instructions powered by AI and proprietary intron advantage.

Frontier Computing

Frontier Computing grows large-scale biological brains for inference-time model training: a compute substrate with memory colocated inside the neurons themselves.

Hedera

Enabling healthcare providers to make better treatment decisions through a platform that makes liquid biopsy tests compliant, easy and cheap.